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Abstract.  We describe the construction in retroviral 
vectors and the expression of recombinant rat fibronec- 
tin (FN) cDNAs corresponding with the various alter- 
natively spliced forms of FN. In NIH 3T3 cells, the 
exogenous rat FN subunits are efficiently secreted as 
heterodimers with endogenous mouse subunits.  In con- 
trast,  in lymphoid WEHI231 cells, there is no endoge- 
nous FN synthesis and the recombinant FNs are 
secreted and can be purified as homogeneous proteins. 
We show that the purified recombinant FNs are bio- 
chemically and biologically functional.  In basic assays 
for adhesion,  spreading,  cytoskeletal organization,  and 
migration using various established adherent cell lines, 
different forms of FNs containing the different alterna- 
tively spliced segments show no marked differences in 
activity. We have used these recombinant FNs to in- 
vestigate three systems in which earlier results had 
suggested potential differences between different forms 
of FN. First,  all forms tested appear equally active in~ 
restoring normal morphology to a transformed cell 
line.  Second, we detect minor differences in their abil- 
ity to assemble into preexisting extracellular matrices. 
Finally, we report that only those forms of FN that 
contain the V  segment will promote the spreading of a 
lymphoid cell line indicating that this segment confers 
additional biological functions for some ceil types, a 
result that confirms and extends earlier data.  These 
homogeneous, biologically active recombinant FNs 
will allow further studies of the role of the alterna- 
tively spliced segments of FN. 
F 
IBROr~ECTINS (FNs) t are multifunctional  extracellu- 
lar  matrix  (ECM)  glycoproteins  that  interact  with 
other ECM components including  fibrin,  collagens, 
and heparin  as well as with integrin  receptors on cell sur- 
faces. These interactions,  probably collectively, promote vi- 
tal cellular functions such as adhesion, spreading, cytoskele- 
ted organization, cell migration,  and matrix formation. These 
basic cellular properties in turn play  important  roles in a 
variety of biological processes, including cell migration dur- 
ing embryonic development,  wound healing,  and oncogenic 
transformation  (Hynes and  Yamada,  1982;  Mosher,  1989; 
Hynes, 1986, 1990). In contrast with these complexities  of 
function.  FNs exhibit a relatively  simple, modular structure 
(reviewed in Hynes, 1985, 1990; Mosher,  1989). The pro- 
tein consists of a dimer of two subunits joined by disulfide 
bonds near their COOH termini.  Each subunit is composed 
of a  series of homologous repeating  units  of three  types 
(types I, II, and HI, see Fig.  1). Several binding activities of 
FN have been successfully assigned  to discrete parts of the 
molecules by using  proteolytic fragments  generated  from 
plasma fibronectins  (pFN). For example,  the short peptide 
sequence Arg-Gly-Asp-Ser  (RGDS)  in  the central  region 
of pFN has been identified  as a primary cell binding  site 
(Pierschbacher  and  Ruoslahti,  1984a,b).  More  recently, 
1. Abbreviation  used in this paper:  FN,  fibronectin. 
however, by using  fusion proteins  containing  various  frag- 
ments of human pFN, Obara et al. (1988) discovered another 
site amino-terminal  to the RGDS sequence that acts syner- 
gistically with it in promoting cell spreading.  Furthermore, 
it has also been reported that the primary cell-binding  do- 
main  and the heparin-binding  domain of FN cooperate in 
functions  such as cytoskeletal organization  and neurite out- 
growth (Woods et al.,  1986; LeBaron et al.,  1988; Rogers 
et al.,  1987).  Thus,  the interactions  of FNs with cells are 
complex, involving several different parts of the FN mole- 
cules. 
Interestingly,  three  segments  (designated  in  rat  FN  as 
EIIIB, EHIA, and V) in the central part of the molecule can 
be included or excluded because of alternative  splicing of a 
single primary transcript  (Kornblihtt et al., 1985; Schwarz- 
bauer et al., 1983, 1987a; Sekiguchi et al., 1986; Norton and 
Hynes,  1987; Gutman and Kornblihtt,  1987; Zardi et al., 
1987). The patterns of splicing are cell type specific; for ex- 
ample,  hepatocytes  synthesizing  pFN  exclude  EHIB  and 
EIIIA, whereas fibroblasts and astrocytes synthesize FNs par- 
tially including these two segments (Kornblihtt  et al.  1984; 
Price and Hynes, 1985; Paul et al.,  1986; Schwarzbaner  et 
al.,  1987a). Furthermore,  recent experiments  using  in situ 
hybridization,  nuclease protection and mAb techniques have 
demonstrated  that the expression of various forms of FN is 
also regulated at different developmental  stages, in a tissue- 
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pathological processes (Vartio et al., 1987; ffrench-Constant 
and Hynes, 1988, 1989; ffrench-Constant et al., 1989; Car- 
nemolla et al.,  1989).  Together,  these findings suggest the 
exciting possibility that alternatively spliced  segments of 
FN may possess unique properties, therefore contributing to 
functionally distinct FN forms. 
Humphries et al. (1986, 1987) have shown, using synthetic 
peptides,  that the V  segment (also called IIICS) contains 
cell-binding activities for certain cell types. To date, there 
are no indications of the functions of the EIIIA and EIIIB 
segments and it has been very difficult to carry out clean ex- 
periments testing the functions of any of these tissue-specific 
segments of FNs in the context of the intact molecules. All 
natural sources of FNs are mixtures of several different types 
of subunits which form many different dimeric forms of FN. 
Thus, the different  dimeric forms contain more than one type 
of FN subunit and share the biochemical properties tradi- 
tionally exploited for protein separation. 
To study the structure-function relationships of rat FNs at 
a finer level and with particular interest in exploring the pos- 
sible functions of the EIIIB, EIIIA, and V regions, we have 
recently undertaken a molecular genetic approach. A series 
of overlapping genomic clones covering the entire gene was 
isolated (Patel et al.,  1987; Schwarzbaner et al.,  1987a). 
cDNA clones corresponding to various parts and different 
forms of the FN mRNA were also isolated from a cDNA li- 
brary or generated from genomic clones using a fusion res- 
cue method (Patel et al., 1987; Schwarzbauer et al., 1987a, 
b). Parts of these cDNAs were expressed in eukaryotic cells 
using  retroviral  expression  vectors  (Schwarzbauer  et  al., 
1987b).  In this study, we first assembled full-length cDNA 
clones encoding eight different possible rat FN forms from 
available cDNA fragments. We then expressed these differ- 
ent rat FNs in heterologous mammalian cells that do not 
themselves produce endogenous FN.  Pure homodimers of 
each rat FN form were then prepared from these expressing 
cell  lines  and  subjected to various functional assays.  We 
show here that recombinant FNs produced from heterolo- 
gous mammalian cells are fully functional in promoting cell 
adhesion,  spreading,  migration and cytoskeletal organiza- 
tion. We have compared the ability of the various forms to 
restore  normal morphology to transformed cells and find 
them equivalent.  Small differences were detected in their 
ability to assemble into preexisting matrices. Finally, only 
those forms of FN containing the V  segment can promote 
spreading of a B lymphocyte cell line, consistent with a cell 
adhesion function for this alternatively spliced segment. 
Materials and Methods 
Cell Cultures 
NIH 3T3 and ~2 cells were grown in DME plus 10% calf serum (CS, Gibco 
Laboratories, Grand Island,  NY).  Mouse B  lymphocyte WEHI231  cells 
(Ralph,  1979)  were kindly provided by  D.  Schatz (Whitehead Institute, 
Massachusetts Institute of Technology) and grown in RPMI 1640 medium 
plus 10% FCS (Gibco Laboratories). NRK, Ratl, and NilS.HSV cells were 
cultured in DME with 5 % FCS. CHO cells were maintained in F-12 medium 
supplemented with 5% FCS. BHK cells were kindly provided by E Grinnell 
(University of Texas, Dallas) and maintained in DME plus 10% FCS. Mu- 
fine melanoma BI6FI0 cells were generous gifts of I. J. Fidler (M. D. An- 
derson Hospital, Houston) and cultured as described (Fidler,  1974). 
Piasmid Construction 
Retroviral vectors containing the 3' third of rat FN eDNA including or ex- 
cluding EIIIA or V have been described previously (Schwarzbauer et al., 
1987b).  Overlapping cDNA clones covering the 5' regions of  the gene were 
generated from the respective genomic clones, hrFN-3, hrFN-5, hrFN-8, 
and XrFN-9 (Patel et al., 1987; Schwarzbauer et al., 1987a),  using a fusion 
rescue method as outlined before (Schwarzbaner et al.,  1987a,b).  These 
eDNA  clones,  including  or  excluding  EIIIB,  were  recombined,  using 
unique restriction sites, with the existing 3' cDNAs to give rise to full length 
cDNAs encoding rat FN. All possible combinations of EIIIB, EIIIA, and 
V were made and the constructs confirmed by restriction mapping. These 
full-length cDNAs extend from a Bal I site (TGC~CA) 50 nucleotides up- 
stream of the initiator cndon of rat FN (Patel et al.,  1987) to a Sac II site 
(CCGCGG) in the 3' untranslated region (Schwarzbauer et al., 1983, 1987b; 
Patel et al.,  1987).  They include the entire coding region of the various 
forms of rat  FN  and  the 3' untranslated region included  in the earlier 
retroviral constructs (Schwarzbauer et al.,  1987b).  Thus, these constructs 
include the natural signal and propeptide segments  of  rat FN to allow normal 
secretion and processing. The  full  length clones were inserted into the 
retroviral expression vector pLJ  to generate pLJ-FN plasmids, pLJ  is a 
derivative of pDOL (Korman et al.,  1987; Schwarzbauer et al.,  1987b), 
from which the 5' splice site has been completely removed, and was gener- 
ated and provided by J. Schwarzbauer. cDNAs to be expressed are inserted 
at a cloning site downstream of the 5' MLV LTR. After the cloning site is 
an SV-40 origin/promoter/enhancer segment and the neomycin resistance 
(neo  ~) gene driven by the SV-40 early promoter and a pBR322 origin of 
replication. 
Transfection of ~b  2 Cells and Infection of NIH 3"1"3  and 
WEHI231 Cells 
Establishment of virus-producing ~b2 cells and infection of NIH 3"1"3 and 
WEHI231  cells were performed as previously described (Schwarzbaner et 
al., 1987b; Landau et al., 1987) with the following modifications. After in- 
fection, NIH 3T3  cells were selected for neo  r expression in G418  (Gibeo 
Laboratories) at a concentration of 0.5 mg/ml. A subset of G418-resistant 
clones was then isolated and clones were expanded for further analysis. 
Infected WEHI231  cells were selected with G418  at a  concentration of 
3 mg/ml. The selected pool of cells was then cloned by limiting dilution. 
Single cell clones that produced the highest amounts of recombinant FNs, 
as determined by immunoprecipitations, were expanded for further analysis. 
Northern Blot Analysis 
Total RNA was isolated from NIH 3T3 cell clones by guanidinium thiocya- 
nate extraction followed by centrifugation through CsCI as described by 
Chirgwin et al. (1979). 20 t~g of  RNA were electrophoresed  in 0.8 % agarose 
gels containing 1.1 M formaldehyde  as described (Lehrach et al., 1977). Af- 
ter electrophoresis,  gels were stained with ethidium bromide to visualize the 
position of 28S-18S ribosomal RNA and the relative RNA content in each 
lane.  The RNA was then transferred to Zeta-Probe blotting membranes 
(Bio-Rad Laboratories, Richmond, CA), which were processed using pro- 
tocols recommended by the manufacturer.  Duplicate RNA samples were 
used for hybridizations with probes corresponding to rat FN eDNA or the 
neo  r gene. The probes were labeled with 32p by random priming (Feinberg 
and Vogelstein, 1984). 
Metabolic Labeling, Immunoprecipitation,  Gelatin and 
Heparin Binding Assays, and SDS-PAGE 
Cells were labeled for 20-24 h with media containing a reduced amount of 
unlabeled  methionine  (10%  of that  in  normal  media)  and  25  ~tCi/ml 
[35S]methionine  (Tran35S-label,  ICN Radiochemicals, Irvine, CA). Condi- 
tioned media were immunoprecipitated using either a rabbit anti-rat FN se- 
rum R61 and goat anti-rabbit IgG or a mouse monoclonal anti-rat FN M9 
(a generous gift of M.  Chiqnet, Carnegie Institute, Baltimore, MD) and 
goat anti-mouse IgG, as described (Choi and Hynes, 1979).  Immunopre- 
cipitates were analyzed either with or without reduction by electrophoresis 
through SDS-PAGE followed by fluorography. Direct binding of FNs in the 
conditioned media to gelatin-coupled Sepharose (Pharmacia Fine Chemi- 
cals, Piscataway, NJ) was carried out as described (Price and Hynes, 1985). 
The bound materials were also eluted by 4 M urea in PBS and used directly 
for binding assays with heparin-coupled Sepharose (Pharmacia Fine Chem- 
icals) as described by Price and Hynes (1985). 
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Recombinant FNs produced from expressor WEHI231  cell clones were 
purified  by  affinity-chromatography using  a  gelatin-coupled  Sepbarose 
column as described by Engvall and Ruoslahti (1977).  Briefly, the express- 
ing clones were grown to saturation in 3 liters of  growth medium. The cells 
were then washed with PBS and resuspended in 10 liters of RPMII640 plus 
5 % FCS that had been passed through gelatin-Sepbarose 4B to deplete FN 
in the serum. The cells were incubated further for 3 d and the conditioned 
media were concentrated and subsequently loaded onto a gelatin-Sepbarose 
4B column. Recombinant FNs were eluted using 4 M urea in CAPS buffer 
(10 mM cyclobexylaminopropane sulfonic acid (CAPS), 150 mM NaCI, 2 
mM EDTA, 2 mM PMSF, pH 11). The peak fractions as determined by UV 
absorption at 280 nm were pooled and dialyzed against CAPS buffer to re- 
move urea. The final concentrations were determined again by UV absorp- 
tion and also confirmed by comparison with protein standards on SDS- 
PAGE followed by Coomassie blue staining. Typical yields were 3-5 mg of 
purified recombinant FN from  10 liters of culture supernatant. 
Cell Spreading Assay 
The biological activities of  recombinant FNs were determined by a quantita- 
tive cell  spreading assay  modified from that  described by  Yamada  and 
Kennedy (1984) and Obara et al. (1988).  Restricted areas of tissue culture 
plates were incubated with 25/~1 of serial dilutions of recombinant FNs for 
2 h at room temperature, followed by incubation with 2 mg/ml heat-treated 
(10 min at 80"C) BSA in PBS for 2 h at 37°C and extensive washing with 
PBS.  Adherent cell lines were harvested by brief trypsinization and then 
washed with PBS containing 0.5 mg/ml soybean trypsin inhibitor (Sigma 
Chemical Co., St. Louis, MO). The cells were added to coated plates at 
IO  s ml in growth media without serum. Suspension WEHI231  cells were 
washed with PBS and added at 2  x  105/ml.  After 2  h  of incubation at 
37°C, the plates were washed with PBS and fixed in 3.7% formaldehyde in 
PBS. Percent cell spreading was then determined by counting three random 
fields (200-300 cells) using a Nikon inverted phase-contrast microscope. 
Other FN Functional Assays 
The effect of various recombinant FNs on NiI8.HSV cells was examined as 
described by Ali et al. (1977).  2 ml of  growth medium containing 2  x  105 
cells were seeded in 35-ram dishes. After 48 h, FNs were added in 100/tl 
PBS to give the desired concentration. Photographs were taken on the Nikon 
inverted phase-contrast microscope 24 h  later. 
To examine their effects on cytoskeletal organization, recombinant FNs 
were used to coat coverslips at various concentrations. Murine melanoma 
BI6F10 cells or fibroblastic BHK cells were then plated onto the coated cov- 
erslips in the absence of serum. 2 h later, the distribution of actin bundles 
and vinculin was visualized by immunofluorescence. Briefly,  cells were 
rinsed twice in PBS and fixed for 15 min in a freshly prepared 4% solution 
of paraformaldehyde (Fluka  Chemical  Co.,  Bern,  Switzerland) in PBS, 
rinsed and permeabilized with 0.5% NP-40 in PBS for 15 min. Cells were 
stained with mouse mAb against vinculin (Sigma Chemical Co.) in 10% 
normal goat serum in PBS for 30 rain at 370C. After three washes with PBS, 
the second antibody mixture (rhodamine-conjugated goat anti-mouse IgG 
and fluorescein-conjugated phalloidin in 10%  normal goat serum in PBS, 
Cappel Laboratories, Cochranville, PA) was added and incubated for 30 
min at 37"C.  After three washes, coverslips were mounted in Gelvatol and 
examined using a  Zeiss Axiophot microscope (Carl  Zeiss, Inc.,  Thorn- 
wood, NY) and photographed using Kodak Tri-X film (Eastman Kodak Co., 
Rochester, NY). 
Cell migration assay was carried out using a Micro Chemotaxis Chamber 
(Neuro Probe Inc., Cabin John, MD) as described by McCarthy and Furcht 
(1984).  Incorporation of recombinant rat FNs into the extracellular matrix 
of NIH 3"1"3 cells was determined by indirect immunofluorescence as de- 
scribed above except that mouse monoclonal M9 and rabbit antiserum R61 
were used as the primary antibody, and fluorescein-conjugated goat anti- 
mouse lgG and rhodamine-conjugated  goat anti-rabbit IgG were used as the 
second antibody. 
Results 
Preparation of  Retroviral Expression Vectors  Encoding 
all Eight Different Rat b]bronectin Forms 
The structure of rat FNs composed of three types of repeat- 
ing peptide units termed Type I, II, and III is diagrammed 
in Fig.  1. Various parts of the molecules that interact with 
fibrin,  collagen,  heparin,  and cell surfaces are illustrated 
above the diagram. Three regions (EIIIA, EIIIB, and V) that 
can be included or excluded in different FN forms due to al- 
ternative splicing are also highlighted. These different rat FN 
forms will be abbreviated as O, B, A, V, BV, AV, BA, and 
BAV forms to indicate the variably included regions which 
they contain. 
Full length eDNA clones encoding eight possible rat FN 
forms were assembled from available eDNA fragments as 
described in  Materials  and  Methods.  The FN  coding se- 
quences in these constructs are identical with the native ones 
including the signal and pro segments of FN. The full length 
clones were then inserted into the retroviral expression vec- 
tor pLJ to generate pLJ-FN plasmids. These plasmids were 
transfected into ~b2 cells to prepare recombinant retroviruses 
containing FN genes as detailed in Materials and Methods. 
The recombinant viruses were used to infect murine recipi- 
ent  cells  including  fibroblastic  NIH  3T3  and  lymphoid 
WEHI231  cells.  The neomycin-resistance gene (neo  r)  en- 
coded in the vector under the control of the SV40 early pro- 
moter  allowed  selection  (with  G418)  of infected  clones. 
These clones were subsequently analyzed for FN expression 
driven by the viral 5' LTR promoter. 
Stable Expression of  Rat Fibronectin in NIH 3T3 Cells 
It was necessary first to test the function of these recom- 
binant  FN genes to ensure appropriate and  efficient tran- 
scription, translation,  and posttranslational processing.  To 
examine the expression of recombinant rat FNs in the context 
of a cell type which normally produces, secretes, and assem- 
bles FN, multiple (3418-resistant clones were isolated from 
infected murine NIH 3T3 cells. Total cellular RNA was pre- 
pared from these clones as well as from parental 3T3 cells 
and then subjected to Northern blot analysis. Fig. 2  shows 
results from one such experiment examining the expression 
of the BAV form of FN. A shows that two transcripts were 
detected from three individual clones infected with retrovi- 
rus containing the BAV form FN gene when the neo  r gene 
was used as probe. The 11.6- and 3.1-kb messages correspond 
with the sizes expected for the full-length genomic transcript 
from the viral LTR and subgenomic RNA from the SV-40 
promoter as diagrammed in C. As expected, no band was de- 
tected in RNA isolated from parental 3T3 cells (lane -). RNA 
Figure 1.  Rat FN structure and binding 
sites.  The rat  FN  subunit composed of 
type I, II, and HI repeating units (boxes) 
is shown schematically. Various domains 
that interact with fibrin, collagen, heparin and cell surfaces are indicated above. The EII1B and EIIIA segments are shown with the filled 
squares while the V  region is represented by a  shaded box. 
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cell clones expressing the BAV form of rat FN as well as control 
parental ceils or cells infected with virus containing the vector pLJ 
alone, as indicated. Duplicate samples were electrophoresed, trans- 
ferred and hybridized with probes corresponding to neo  r gene (top 
left) or rat FN eDNA (top right) as described  in Materials  and 
Methods. The positions of mRNAs corresponding to rat FN (rFN), 
endogenous mouse FN (mFN), and neoresistance gene (Neo-R) are 
marked in the center. The expected genomic and subgenomic tran- 
scripts from pLJ-FN plasmids are diagrammed below (bottom). The 
viral LTR promoters are indicated at both ends while FN cDNA, 
neo-R gene, and SV-40 promoter are represented by boxes filled 
with wider lines, thinner lines,  and dots respectively. 
isolated from cells containing pLI vector alone included the 
3.1-kb subgenomic RNA and a minor band migrating at 3.9 
kb, which corresponds with a transcript derived from the 5' 
viral LTR.  The identity of the  ll.6-kb transcript was con- 
firmed by hybridizing the same blot with a  probe derived 
from rat FN eDNA (B). This probe also detects the endoge- 
nous murine FN message (8.1 kb), which is present in rat FN 
expressor clones as well as in the control cell lines. The rat 
FN mRNA signal was "o10%  of the signal for endogenous 
murine FN mRNA. Therefore, eDNA clones for rat FNs are 
readily transcribed in murine 3T3 cells under the control of 
the MLV-LTR promoter. 
To detect and quantitate secretion of recombinant rat FNs 
from 3T3 cells,  immunoprecipitations of supernatants har- 
vested from [35S]methionine-labeled cells were carried out 
with a mouse mAb, M9, specific for rat FN or with an anti- 
rat FN  polyclonal serum R61. SDS-PAGE analysis of im- 
munoprecipitates from representative clones expressing O, 
B, V, or BV rat FN forms is shown in Fig.  3. As shown in 
the left panel, all these forms of rat FN were secreted into 
the  medium  as  proteins  with  molecular  masses  around 
220-250 kD. The slight differences in molecular weight are 
as expected from their differences in polypeptide chain by in- 
cluding neither, either or both of the E~IB and V  regions. 
As seen most evidently in cells secreting the O  form of rat 
FN, the endogenous mouse FN (a mixture of different forms 
but mostly larger than the O form) is coprecipitated with M9. 
This  result  shows  that  the  recombinant rat  FN  can  form 
dimers with the endogenous mouse FN which has been ob- 
served before for 3T3 cells expressing the COOH-terminal 
third of rat FNs (Schwarzbauer et al.,  1987b). The two left- 
most lanes show that no endogenous FNs were precipitated 
by M9 from supernatants of 3T3 parental cells or clones in- 
fected  with  vector alone.  The  right panel  shows  the  im- 
munoprecipitations  with  the  polyclonal  anti-FN  serum, 
demonstrating  that  all  these  clones  secrete  comparable 
amounts of total fibronectins.  Estimates from densitometry 
of the autoradiographs showed that the recombinant rat FNs 
secreted from 3T3 cell clones represent ~10%  of the total 
FNs produced by these cells. This estimate corresponds well 
with the  10%  rat FN transcripts compared with total fibro- 
nectin message as determined from Northern blot analysis 
(Fig. 2).  Thus, the chimeric rat FN mRNAs are efficiently 
translated  and  the  rat  fibronectins expressed in  stable  in- 
fected NIH3T3 cell clones are efficiently processed, assem- 
bled into dimers and secreted into the medium. These cells 
also assemble the recombinant rat FNs into extracellular ma- 
trix (data not shown but see below). 
Therefore, the recombinant FN genes appear to function 
exactly as expected. However, because interspecies FN het- 
erodimers form in these cells, it is not possible to assay the 
behavior of pure recombinant FNs. 
Isolation of B Lymphoma WEHI231 Cell Clones 
Producing Recombinant ~bronectins 
To  prepare  large  quantities  of homogeneous  recombinant 
FNs  for  further  studies,  recombinant  viruses  containing 
genes for O, B, A, and V forms of rat FNs were used to infect 
a  murine B  lymphoma cell line WEHI231  which does not 
produce any endogenous FN  (as shown below). WEHI231 
cells were infected by coculture with virus-producing ~b2 cell 
Figure 3.  Secreted recombinant FNs from NIH 3T3 cells. Condi- 
tioned  supernatants  from [35S]methionine-labeled cells  were im- 
munoprecipitated with either the mAb M9 (rat FN, left six lanes) 
or the polyclonal antiserum R61 (total FN, right six lanes). Immune 
complexes were  subjected  to SDS-PAGE under  reducing  condi- 
tions. The molecular weight markers are shown on the right. 
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duced by WEHI231 cells. Conditioned cul- 
ture  media  from  [35S]methionine-labeled 
cells  were each divided  into four aliquots 
and subjected to the following treatments. 
The first two aliquots were immunoprecipi- 
tated with rabbit antiserum R61 and electro- 
phoresed  either under  nonreducing  (A) or 
reducing (B) conditions.  The positions  of 
the  FN  monomer and  dimers  (FN2) are 
marked at the left. The third aliquot was in- 
cubated with gelatin-Sepharose, washed and 
eluted  with  electrophoresis  sample  buffer 
followed by SDS-PAGE (C).  The last ali- 
quot was incubated with gelatin-Sepharose 
and the bound materials  were eluted with 
urea in PBS and then incubated with hepa- 
rin-Sepharose.  The  bound  proteins  were 
then  dissolved  in  sample  buffer and  ana- 
lyzed  by SDS-PAGE (D).  The molecular 
weight markers shown on the right are 200, 
97, and 68 kD. 
lines as detailed in Materials and Methods.  The single cell 
clones secreting the corresponding rat FNs were then iso- 
lated  by  limiting  dilution  from  the  G418-resistant  pools. 
Secretion of various forms of rat FNs was determined by im- 
munoprecipitation using the polyclonal antiserum Ii61  fol- 
lowed by SDS-PAGE analysis in the presence or absence of 
reducing agents. As shown in Fig. 4, a major protein product 
migrating at 220-250 kD was immunoprecipitated from the 
media of [3~S]methionine-labeled cell clones expressing the 
O, B, A, or V forms of rat FNs (B). The apparent molecular 
weights of the proteins are as expected for the various rat FN 
forms and also correspond with those of rat FNs expressed 
in NII-I3T3 cells as described above. This suggests that no 
major different posttranslational modifications occurred in 
recombinant FN  synthesized  in  lymphoid WEHI231  cells 
which normally do not produce any endogenous FNs (see 
pLJ lane). 
FNs are dimeric molecules linked by interchain disulfide 
bonds near their COOH termini. Fig. 4  (A) also shows that 
all four forms of FN produced from WEHI231 cells can form 
dimers in the absence of reduction.  However differences in 
dimerization efficiency were observed for the different FN 
forms. About 50% of the O form of rat FN was found in the 
dimeric form as determined by densitometry, whereas the 
majority of the B or A forms exist as monomers and ~90% 
of the V form is dimeric. These results suggest that the alter- 
natively included V  segment in FN may promote dimeriza- 
tion while the EIIIB and EIIIA segments may reduce it (see 
Discussion). 
Two important biochemical properties of FNs are their 
abilities to interact with collagen and heparin both in vivo 
and in  vitro.  To examine these activities for the recombi- 
nant FNs, conditioned media from [3sS]methionine-labeled 
WEHI231 cells expressing these various FNs were incubated 
with  gelatin-  or  heparin-coupled  Sepharose beads,  eluted 
and analyzed (Fig.  4).  C  shows that these FNs bind effec- 
tively to gelatin-Sepharose. Eluates from the gelatin-Sepba- 
rose  were  shown  to  bind  heparin-Sepharose efficiently at 
physiological salt concentrations  (D).  Furthermore,  the O, 
B, A, and V forms of rat FNs each bind to gelatin and heparin 
to a similar extent (from densitometric data not shown, com- 
pare  B-D).  Therefore,  recombinant  FNs  produced  from 
lymphoid WEHI231 cells are biochemically functional. Fur- 
thermore, there are no major effects on these functions con- 
tingent upon inclusion or omission of any of the three alter- 
natively spliced segments. 
Recombinant Fibronectins Are Active in Cell Adhesion 
and Spreading 
To determine their  biological activities,  recombinant FNs 
were purified from conditioned culture media of expressing 
WEHI231  cell lines by gelatin-Sepharose affinity chroma- 
tography as described in Materials and Methods. The puri- 
fied O, B, A, and V FNs were subjected to SDS-PAGE and 
visualized  by  Coomassie blue  staining  (Fig.  5).  All  four 
forms of FN migrate on the gel as single bands that comigrate 
with rat pFN subunits (not shown).  The molecular masses 
are around 220-250  kD under reducing conditions,  as ex- 
pected for FN monomers. The sizes of the various forms of 
Figure 5.  Purification of recombinant FNs.  Recombinant rat FNs 
were purified by gelatin-Sepharose affinity chromatography as de- 
tailed in Materials and Methods.  Aliquots of the purified proteins 
were subjected to SDS-PAGE (two lanes for each form) and visual- 
ized by Coomassie blue staining. The molecular  mass marker of 
200 kD is shown on the right. 
Guan et al. Heterologous Fibronectin Expression  837 Figure 6. The spreading  of BI6F10 melanoma cells on the A form of FN. B16F10 melanoma cells were seeded  on tissue culture plates 
coated with various amounts of  the A form of FN as indicated.  2 h later, cells were rinsed and fixed with formaldehyde in PBS. Photographs 
were taken on a Nikon inverted  phase-contrast microscope, Similar  results  were observed with the other forms of FN. 
purified FNs are slightly different, in agreement with differ- 
ences in their  primary sequences.  These results  also indi- 
cated that recombinant FNs produced by WEHI231 lympho- 
cytes are indeed homodimers free of contamination with FN 
from natural  sources. 
The biological  activities  of recombinant  FNs  were  first 
tested using a  cell  spreading  assay modified from that de- 
scribed by Yamada and his colleagues (Yamada and Kennedy, 
1984; Obara et al., 1988; see Materials and Methods for de- 
tails).  Several  different adherent  cell lines,  including NIH 
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Figure  7.  BI6F10 melanoma cells spread  on all forms  of recom- 
binant FNs. The spreading  of BI6FI0 melanoma cells on all four 
forms of recombinant FNs were determined and quantitated as de- 
scribed in Materials and Methods. The average scores from three 
independent experiments are plotted here. The SDs were <10% on 
all points and are not shown. 
3T3,  NRK,  Raft,  CHO,  BHK,  and  murine  melanoma 
B16F10,  were tested in these assays. We found that all four 
forms of recombinant FNs (O, B, A, and V) promote adhe- 
sion and spreading of all the cell lines tested here.  Fig.  6 
shows one representative experiment with the mouse mela- 
noma cell line B16F10. On control substrata coated only with 
BSA, the cells either did not attach, or spread poorly (top). 
On substrata coated with a low amount of recombinant FN 
(in this case 2 #g/ml A  form), significantly increased num- 
bers of cells attach, but relatively few assume a well-spread 
morphology (center).  When plated on higher doses of FNs 
(16  #g/ml  A  form),  the  majority of the  cells adhere  and 
spread well (bottom).  These results,  as well as similar ex- 
periments with the other cell lines mentioned above, indi- 
cated that all four forms of FNs tested are biologically active 
in promoting cell adhesion and spreading.  Furthermore,  it 
appeared that all these forms of recombinant FNs promote 
cell adhesion and spreading to a similar extent. This observa- 
tion was confirmed by quantitative measurements shown in 
Fig. 7 for B16F10 melanoma cells. The percentages of cells 
spreading are plotted as average scores for three independent 
experiments and the SDs were <10%. This experiment dem- 
onstrated  that  these  four  forms of recombinant FNs  have 
similar  dose-response  curves  in  promoting  B16FI0  cell 
spreading, reaching saturating concentration at ,,o10 #g/ml. 
This is comparable with the doses of pFN required to pro- 
duce similar effects (data not shown). These results suggest 
that, in the basic adhesion and spreading assays with these 
established adherent cell lines,  all forms of FN  tested are 
equivalent (see Discussion). 
Other Biological Properties of Recombinant 
Fibronectins 
Having established  that  the  recombinant FNs  were  func- 
Figure 8.  Effects of the V form of FN on the cytoskeletal organization of BI6F10 melanoma cells.  BI6FI0 melanoma cells were plated 
on coverslips that had been coated with the V form of FN at two different concentrations  (top and bottom). 2 h later, cells were rinsed, 
fixed and stained for actin (left) and vinculin (right) by double-label  immunofluorescence. 
Guan  et al. Heterologous Fibronectin Expression  839 Figure  9.  Cytoskeletal  organization  of 
BI6FIO melanoma  cells  spread  on re- 
combinant FNs. BI6FI0 melanoma cells 
were  plated  on coverslips coated  with 
various forms of recombinant FNs at 20 
#g/ml and  their  cytoskeletal organiza- 
tion was depicted by immunofluorescent 
staining of actin bundles (left) and vin- 
culin (righO.  Note that all three  forms 
(O, V, and B) promoted cytoskeletal or- 
ganization of these cells. Similar results 
were obtained with the A form. 
tional in the basic binding functions of FN and in cell adhe- 
sion  and  spreading,  we  sought  next  to  investigate  the]'r ~ 
efficacy in more complex biological functions. 
Through their transmembrane integrin receptors, extracel- 
lular FNs can induce cytoskeletal organization including or- 
ganized actin bundles and focal contact formation. To exam- 
ine  these  transmembrane effects,  B16F10  melanoma cells 
were cultured on substrata coated with various recombinant 
FNs. 2 h later, cells were fixed and stained for F  actin and 
vinculin  distribution  using  double-label  immunofluores- 
cence.  When  low concentrations  of the various FNs were 
used, actin bundles were visualized in only a small percent- 
age of cells while diffuse and unorganized patterns were evi- 
dent for most cells.  Similarly, few focal contacts were de- 
tected as determined by staining for vinculin (top,  Fig.  8). 
When plated on higher concentrations of FNs however, ex- 
tensive microfilament bundles were detected for the majority 
of cells and discrete focal contacts were localized at termini 
of actin bundles (bottom,  Fig. 8). These results indicated that 
recombinant FN V form was able to induce cytoskeletal or- 
ganization. Similar effects were observed for the other forms 
of FNs obtained from WEHI231  cells (O,  V,  B  forms are 
shown in Fig.  9). 
Next, we examined the ability of recombinant FNs to pro- 
mote cell migration. A  modified Boyden chamber assay as 
described  by McCarthy and Furcht  (1984)  was employed. 
Several  cell  lines  including  NIH3T3,  BHK,  B16FIO,  and 
NiI8.HSV were tested in these assays. Fig.  10 shows a repre- 
sentative result with Nil8.HSV cells in response to A  form 
FN.  In  control  wells  with  no  FN  added,  very  few  cells 
migrated through the membrane with holes of suitable size 
(left).  When FN was added to the other side of a membrane, 
significant numbers  of cells migrated through  membranes 
(right).  Cells per unit area were counted; all four forms of 
FNs promoted cell migration to similar extents (Table I). 
Therefore, as for adhesion and spreading, the four forms 
The Journal of Cell Biology, Volume  I10,  1990  840 Figure 10.  Recombinant FN-mediated migration of NiI8-HSV cells. Cell migration assay was carried out as described in Materials and 
Methods. Cells that migrated through the membrane in response to FN were visualized by Giemsa stain. (Left) shows the control where 
very few cells migrated when no FN was added. (Right) shows cells migrated when the A form of FN was added to the buffer. Similar 
results were obtained with the other forms of FN. 
of FN tested (O, B, A, and V) all appeared equally effective 
in promoting cytoskeletal organization and cell migration in 
the cell types tested. 
We turned next to investigate the functions of the different 
forms in several assays where there have been suggestions 
that different forms of FN might differ in effectiveness. One 
striking  morphological phenotype of transformed cells  is 
their reduced adhesion to substrata. At least in some cases, 
the reduction in adhesion can be accounted for by their re- 
duced levels of cell surface-associated FNs (Yamada  et al., 
1976;  Ali et al.,  1977;  Willingham et al.,  1977).  Further- 
more, addition of exogenous FNs to these transformed cells 
increases their attachment to the substrata, and causes them 
to spread out and adopt a more flattened morphology resem- 
bling  that  of normal  cells.  Yamada  and  Kennedy  (1979) 
reported  that  cellular  FNs  presumably  containing  some 
Table L Migration of  Nil8. HSV Cells in Response 
to Fibronectin 
1.25 ~g/ml  2.5 tzg/ml  5.0/zg/ml  10.0 t~g/ml 
O  38,7  +  6.1  138.0  +  4.0  224,3  +  17.5  211.7  +  12.1 
B  35.3  +  4.2  153.3  +  3.8  211.3  +  19.5  216.3  +  16.0 
A  43.3  +  6.4  162.7  +  21.2  206.0  +  5.3  215.3  +  12.5 
V  42.7  +  5.9  159.0  +  10.8  185.0  +  4.4  222.7  +  18.6 
Cell migration assays were carded out as described in Materials and Methods. 
The number of migrated cells per high-power  field (x250) was counted and 
the average score of three independent experiments is shown with SDs. In the 
absence of PN, fewer than five cells migrated. 
EMB and EMA segments were 50-fold more effective than 
pFNs lacking these two segments in reverting the morphol- 
ogy of transformed cells. Others, however, did not detect the 
same differences between plasma and cellular FNs (Hynes 
et al.,  1978).  Using purified homodimers of recombinant 
FNs, we carded out similar experiments on HSV-transformed 
hamster Nil8 cells to determine the contributions of EIIIB 
and EIIIA in this activity. As shown in Fig.  11 (top), a sub- 
stantial population of Nil8.HSV cells are rounded and de- 
tached from the substrate.  The middle and bottom panels 
show that cells assumed a more flattened and aligned mor- 
phology upon addition of the recombinant FN A form. Simi- 
lar effects were also observed for O, B, V forms of FNs (not 
shown). The differences in dose response among the differ- 
ent forms were, at most, two to threefold in different experi- 
ments. Therefore, in agreement with results obtained from 
basic adhesion and spreading assays using adherent cells, the 
ability of FN to revert the morphology of these transformed 
cells does not appear to reside in the EIIIB, EIIIA, or V 
regions. 
Although pFN can incorporate into preexisting extracellu- 
lar matrices in vitro (Hayman and Ruoslahti,  1979) and in 
vivo (Oh et al., 1981), this form of FN is generally a soluble 
protein. Purified PN from cells is generally of lower solubil- 
ity (e.g., Yamada et al.,  1977; Alexander et al., 1978, 1979) 
and it has often been proposed that it could be more effective 
in  assembly  into  extracellular matrices.  Accordingly,  we 
compared the ability of recombinant FNs lacking (O and V 
forms) or containing (A and B forms) the segments charac- 
Guan et al. Heterologous Fibronectin Expression  841 Figure 11. Effects of the A form of FN on the morphology of NiI8-HSV. Various amounts of the A form of recombinant FN were added 
to subconfluent Nil.8-HSV cells as described in Materials and Methods. 24 h later, pictures were taken under the phase contrast microscope. 
Note the flattened morphology of cells treated with recombinant FN (middle and bottom)  in comparison  with the control (top).  Similar 
results were obtained with the other forms of FN. 
teristic of"cellular" or "tissue" FN to assemble into preexist- 
ing extracellular matrices. Mouse 3T3 cells were plated and 
grown to near confluency. Recombinant rat FNs were then 
added and incubated with 3T3 cells for 16 h. Cell layers were 
subsequently fixed and rat FNs were detected by indirect im- 
munofluorescence using mAb M9 (Fig.  12).  The right-hand 
panels show that recombinant rat FNs formed fibrillar net- 
works characteristic of the usual extracellular matrix distri- 
bution of FN.  Furthermore, total extracellular FN staining 
(with polyclonal antiserum R61) increased significantly upon 
addition  of exogenous  recombinant  FNs,  indicating  their 
contribution to matrix formation. All forms of FNs incorpo- 
The Journal of Cell Biology, Volume 110,  1990  842 Figure  12. Incorporation of recombinant FNs into the existing matrix of NIH3T3 cells. Exogenous recombinant FNs at indicated concentra- 
tions were added to confluent NIH3T3 ceils and incubated for 20 h. The incorporation of the recombinant rat FNs into the matrix was 
visualized by immunofluorescence using a rat-specific monoclonal M9 (right) or a rabbit polyclonal R61 (left). 
rated into the existing matrices. However, we noted two- to 
threefold differences in the doses of recombinant FNs re- 
quired to give a particular level of rat FN-specific fluores- 
cence. The O and V forms required higher levels added than 
did the A and B forms to give equivalent staining. Minimum 
doses for detectable M9 staining were 10 #g/ml for B or BAV 
and 30 #g/mi for V. Fig. 12 shows approximately equivalent 
incorporation of rat FN at 30 #g/ml B form and 90/~g/mi 
V form. These results suggest that inclusion of the EIIIA or 
ElfiB segments characteristic of tissue FN may enhance the 
ability of FN to incorporate into existing matrix. 
A  Unique Function of  Alternatively Spliced V Segment 
in Promoting Lymphocyte Spreading 
Our observation that O, B, A, and V FNs promote adhesion 
and spreading of adherent cell lines to a similar extent may 
not be surprising because all these cell lines contain integrin 
c~fl~ on their surfaces (our unpublished data).  It is known 
that ~5/~1 is the predominant FN receptor that interacts with 
the RGDS sequence in FN (Pytela et al., 1985; Ruoslahti and 
Pierschbacher,  1987;  Buck  and  Horwitz,  1987;  Hynes, 
1987). The RGDS sequence is included in all four forms of 
FNs tested, Thus, it is both important and necessary to test 
other cell lines, preferably ones lacking otsfll, to detect any 
possible functional differences in cell adhesion among these 
forms. 
Earlier papers had  suggested that  some lymphoid cells 
might bind to a site in FN distinct from the RGDS sequence 
(Bernardi et al.,  1987;  Liao et al.,  1989).  This  site was 
mapped to the COOH terminal part of FN,  in or near the 
heparin-binding site. Since we were expressing the recom- 
binant FNs in a  lymphoid cell line, WEHI231,  we inves- 
Guan  et al.  Heterologous Fibronectin Expression  843 Figure 13. WEHI231 cells spread only on the V form of FN. WEHI231 cells were seeded on surfaces coated with the A, B, O, or V forms 
of FNs (A, B, C, and D, respectively). 2 h later, cells were rinsed and photographed in a phase-contrast microscope. Note that only ceils 
on the V form of FN assumed a well-spread morphology with clearly visible nuclei. 
tigated the response of these cells to various forms of FN. 
When the expression pattern of the integrin 13~ subfamily was 
examined for mouse WEHI231 cells, we found on the surface 
very  little  or  no  Ots/~ or  ot3/3~, two  integrin  complexes 
known to interact with FNs (data not shown).  However we 
noticed that a proportion of WEHI231 cells expressing V FN 
were  attached  and  even  spread  on  the  bottom of culture 
flasks, whereas those expressing the O, B, or A  forms and 
parental  WEHI231  cells  all  grew  as  suspension  cultures. 
However, these expressor cell lines were isolated single-cell 
clones and they produce different amounts of FNs.  Thus, 
their different behavior could be either a clonal difference or 
caused by differences in the amount of FNs accumulated in 
the media rather than by specific effects of the V  segment. 
To clarify this issue, purified recombinant FNs were used 
in  experiments analogous  to  those  described  for adherent 
cells. It has been observed before that WEHI231 cells can at- 
tach to pFN although their nonspecific attachment to BSA is 
quite  high  (Bernardi  et al.,  1987).  We also observed that 
WEHI231 cells can partially attach to BSA-coated substrata. 
Nevertheless,  our  assays  measuring  percent  of spreading 
cells avoided this background problem since none of the cells 
spread on BSA-coated surfaces. Figure 13 shows a represen- 
tative experiment where the A, B, O, or V recombifiant FNs 
were used. It is evident that none of the A, B, or O FN forms 
promote lymphocyte spreading (A, B, and C), whereas V FN 
did so significantly (up to 70%, D). These results therefore 
indicated that the alternatively spliced V  segment functions 
to promote spreading of B lymphocytes in vitro, presumably 
via some other cell surface receptor (see Discussion). 
Discussion 
In nature, FNs are usually mixtures of several distinct forms 
resulting from the alternative splicing at three regions of the 
gene transcript (EIIIB, EIIIA, and V in rat, Patel et al., 1987; 
Schwarzbauer et al.,  1987a).  The differential expression of 
various forms is both developmentally regulated and tissue 
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significance to the heterogeneity (Vartio et al., 1987; ffrench- 
Constant and Hynes, 1988,  1989; Carnemolla et al.,  1989). 
For instance the EIIIA and  EIIIB segments  are prevalent 
when there is abundant cell proliferation and migration, ei- 
ther  during  development  (ffrench-Constant  and  Hynes, 
1988),  or during  wound healing  (ffrench-Constant et al., 
1989) and the EIIIA segment is selectively excluded by cells 
such as hepatocytes and chondrocytes that do not assemble 
FN-rich  matrices  (ffrench-Constant  and  Hynes,  1989). 
These descriptive studies allow one to develop hypotheses 
for the potential roles of the alternatively spliced segments 
but it is necessary also to test such hypotheses. This has been 
difficult because the form of FN available in quantity is pFN, 
which lacks EIIIA and EIIIB, and FN from other sources, 
even when available,  is  a  mixture of various  forms.  The 
recombinant FNs we describe here offer a solution to this 
difficulty. By expressing these recombinant FNs in a  cell 
type which expresses no endogenous FN we are able to ob- 
tain pure homogeneous FNs with any desired combination 
of alternatively spliced segments. 
In the present report, we concentrated on four forms of rat 
FNs containing none or one of the extra segments (called O, 
B, A, and V  forms, respectively). We found that all these 
four forms were expressed efficiently in  both fibroblastic 
NIH 3T3 cells and lymphoid WEHI231 cells via retroviral 
expression vectors. The recombinant FNs can assemble into 
dimers and be secreted into the media. They bind to gelatin 
and  heparin efficiently and  specifically in  vitro.  Further- 
more,  we  showed  that  recobminant  FNs  produced  by 
WEHI231 ceils were fully functional in a variety of biologi- 
cal  assays  including  cell  adhesion,  spreading,  migration, 
cytoskeletal organization, and matrix formation. 
Although all four forms of FNs tested can form homodi- 
mers to some degree, the V form of FN did so most effec- 
tively. This is in agreement with previous observations by 
Schwarzbauer et al. (1987b,  1989) who reported that the V 
segment is necessary for dimer formation in NIH3T3 cells 
and showed that pFN is predominantly a heterodimer of V 
and O  subunits.  However, in our system, ,x,50%  of the O 
form of FN is dimeric, indicating that the V segment is not 
absolutely required for dimer formation in WEHI231 cells. 
Interestingly, inclusion of the EIIIA or EIIIB segment ap- 
peared to reduce dimer formation (Fig. 4). It is unclear how 
the monomers arise and are secreted. The two cysteine residues 
normally involved in  intersubunit disulfide bonds may be 
free or form atypical disulfide bonds.  The significance of 
these results is not clear since virtually all endogenous FN 
secreted by cells is dimeric. Most cellular FNs which contain 
EIIIA or EIIIB also contain V. It remains to be investigated 
how efficiently dimers form from recombinant FNs contain- 
ing two or three extra segments. Perhaps there is a require- 
ment for heterodimerization which in pFN is satisfied by the 
presence of V + and V- (i.e., O) forms and in other forms of 
FN is  satisfied by the presence of mixtures of A + and B  + 
forms. In spite of their differences in dimerization, all four 
forms of FNs seemed to be secreted efficiently into the me- 
dia. Thus, dimer formation is not necessary for extracellular 
transport of FNs. Furthermore, their abilities to interact with 
collagens and heparin were not affected in vitro, which is not 
surprising since these biochemical activities can be retained 
even by monomeric proteolytic fragments (Mosher,  1989; 
Hynes, 1990). 
Turning to the biological properties of the various recom- 
binant FNs,  one can note several things.  First,  all appear 
equally  functional  in  the  basic  assays  of cell  adhesion, 
spreading, migration, cytoskeletal organization, and matrix 
assembly, at least when assayed with a variety of established 
cell lines. This again is not particularly surprising because 
pFN is active in these assays as are various proteolytic frag- 
ments of pFN and cellular FN.  The various forms of FN 
share the great majority of the segments including the well- 
defined domains for binding to cells, heparin, and collagen 
(Fig.  1). It is to be expected that they will share many func- 
tions as we report here. However, note that the cells tested 
here are all established cell lines, which we used for pur- 
poses of  comparison with the previous literature on FN func- 
tions. These experiments establish that the recombinant FNs 
behave as expected and prepare the ground for analyses with 
other cell types and in more complex biological assays. 
In initial extensions of  these experiments, we have reexam- 
ined three questions arising from the earlier literature con- 
cerning potential differences among different forms of FN. 
The first of these concerns the ability of FNs to revert the 
morphology of some oncogenically transformed cells toward 
normal (Yamada et al.,  1976; Ali et al.,  1977). Yamada and 
Kennedy (1979) reported that FN purified from cell layers 
(cFN) was 50-fold more effective in this assay than was FN 
purified from plasma (pFN) and suggested that this was  a 
functional difference between pFN and cFN. To test whether 
this reported difference in function is dependent on the pres- 
ence of any of the alternatively spliced segments, we tested 
homogeneous recombinant  FN  forms containing  each  or 
none of the three segments. We were unable to detect sig- 
nificant differences in activity among the four forms tested; 
at most, they differed by two to threefold in efficacy in this 
assay. It remains possible that differences will emerge when 
recombinant FN forms are tested which contain more than 
one alternatively spliced segment. At present, it appears pos- 
sible that the reported differences between cFN and pFN in 
this assay are not due to alternative splicing of FN and may 
instead arise from differences in preparation or minor con- 
taminants. 
The second difference in function of pFN and cFN which 
has been suggested in the literature is in their ability to as- 
semble into matrices. Although pFN can assemble into ma- 
trices both in vitro (Hayman and Ruoslahti,  1979) and in 
vivo (Oh et al.,  1981), the reported differences in solubility 
between the two forms (Yamada  et al.,  1977; Alexander et 
al.,  1978,  1979)  have been adduced to suggest that pFN, 
which is normally a soluble protein in plasma, may be less 
effective in forming matrices than the forms of FN produced 
by cells and found in tissues. To test whether the inclusion 
of any of the alternatively spliced segments enhances the 
ability of FN to assemble into preexisting matrices, we tested 
various forms of recombinant FN. As described in the Re- 
sults section, those forms which contain the EI/IB or EIIIA 
segments did appear to be more efficient (Fig. 12).  Further 
work will be necessary to investigate this possibility in ex- 
perimental cell systems that do not contain endogenous FN. 
The WEHI231 producer cells are incompetent in assembly 
of  extracellular matrix but the retroviral constructs described 
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cell types so it should be feasible to test the ability of FN 
forms with one, two, or three of  the alternatively spliced seg- 
ments to construct a matrix de novo. 
The one major difference which we did detect among the 
different forms of FN  was  in promoting the  spreading  of 
WEHI231 lymphoid cells. In this assay, only the V form of 
FN was active (Fig. 13). Humphries et al. (1986,  1987) have 
shown that a synthetic peptide corresponding to part of the 
human FN V region (also called IIICS) can promote adhe- 
sion and spreading of mouse melanoma B16F10 cells. How- 
ever, we did not detect significant differences in the ability 
of the O  and V  forms of recombinant rat FN to promote 
B16FI0 adhesion and spreading.  Although we can not ex- 
clude completely the possibility that material and experi- 
mental differences are responsible for our different observa- 
tions,  we favor instead the following explanation.  B16F10 
melanoma cells may possess two receptor systems that inter- 
act with FNs, perhaps on different sites. It is likely that these 
two sites reside in the classic RGDS sequence with its syn- 
ergy site and in the CS1 (V25) site identified by Humphries 
et al. (1986,  1987). Both sites can mediate the adhesion and 
spreading of B16F10 cells to some degree. However in the 
whole molecule (such as our O and V forms), the effect of 
the V region site may be masked either due to conformational 
constraints or due to a relatively lower efficiency compared 
with the RGDS  site under our assay conditions.  In  other 
words, that we did not find that the V form is twice as effec- 
tive as  the O  form suggests  that the  V  region site  is  not 
equally active as the RGDS sequence. However, the limits of 
sensitivity of our assay do not allow us to conclude that the 
V25 site is totally inactive in our experiments. In any case, 
it appeared that the RGDS  site was the predominant cell- 
interacting domain for B16FI0 melanoma cells in our in vitro 
assays.  In agreement with this, we found abundant expres- 
sion of ots/~m integrin on the surface of these cells (our un- 
published results). This integrin is the primary receptor for 
the RGDS  site in  FN  (Pytela et al.,  1985;  Ruoslahti and 
Pierschbacher,  1987;  Buck  and  Horwitz,  1987;  Hynes, 
1987). It seems likely that, in vivo, both of these two adhe- 
sion systems may function and either one can be dominant 
in certain situations. 
This example of the ots/~t/RGDS system obscuring other 
cell interacting sites makes clear the desirability of using cell 
lines lacking ots/~t integrin to detect any possible functional 
differences in promoting cell adhesion and spreading among 
these forms of recombinant FNs.  In the present study, we 
found that the B lymphoid cell line WEHI231, which lacks 
a5/$~, spread only on the V form of FN, but not on the other 
forms. One trivial explanation for this would be that the V 
form of FN exists mostly as dimers and only dimeric FN can 
interact with WEHI231 cells. This is unlikely because the O 
form (with 50% as dimers) did not promote WEHI231 cell 
spreading at all.  These results therefore suggest a  unique 
function for the alternatively spliced V segment in promoting 
lymphocyte spreading. Bernardi et al. (1987) and Liao et al. 
(1989)  have recently shown that FN can increase adhesion 
of several B lymphoid cell lines including WEHI231 cells. 
These workers have localized a  site near the high-affinity 
heparin-binding domain of FN which is active in increasing 
adhesion of several B cell lines. Since the V segment is close 
to that region in the pFN fragment they used, it is likely that 
the activity they described may be attributable to the V seg- 
ment. This suggests that our observation of the effects of the 
V segment on B lymphocytes is widespread and may perform 
some important role in vivo. While this paper was under re- 
view, a paper by Wayner et al. (1989) reported that lymphoid 
cells can attach to FN via interaction of a different integrin, 
ot4/$~, with CS1 (V25) peptides, which is in agreement with 
our own recent results (Guan and Hynes, 1990). The recom- 
binant FNs we describe here are now being used to inves- 
tigate this system in greater detail. It is clear that it will be 
very fruitful to explore the effects of various recombinant 
FNs on other specialized cellular systems both in vitro and 
in vivo, especially with cells lacking the classic FN receptor, 
ots/~t integrin. It is likely that inclusion of more than one of 
these segments may change the properties of FN in some of 
these  assays.  Experiments  testing  these  ideas  are  now  in 
progress. 
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